Monoclonal Antibody against CXCL1 (HL2401) as a Novel Agent in Suppressing IL6 Expression and Tumoral Growth

DOI: 10.7150/thno.29553

Keywords: bladder cancer, CXCL1, IL6, prostate cancer, TIMP4

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text